Windtree Therapeutics Stock Today
| WINTW Stock | USD 0.0009 0.0001 12.50% |
Performance22 of 100
| Odds Of DistressOver 55
|
Windtree Therapeutics is selling for under 9.0E-4 as of the 27th of April 2024; that is 12.50 percent increase since the beginning of the trading day. The stock's lowest day price was 9.0E-4. Windtree Therapeutics has over 55 % chance of experiencing financial distress in the next 2 years of operation, but had a somewhat solid returns during the last 90 days. Equity ratings for Windtree Therapeutics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of March 2024 and ending today, the 27th of April 2024. Click here to learn more.
Windtree Therapeutics, Inc., a biotechnology and medical device company, engages in the research and development of products that focus on acute pulmonary and cardiovascular diseases. Windtree Therapeutics, Inc. was incorporated in 1992 and is headquartered in Warrington, Pennsylvania. The company has 0 outstanding shares. More on Windtree Therapeutics
Moving against Windtree Pink Sheet
| 0.53 | GOOG | Alphabet Class C Buyout Trend | PairCorr |
| 0.5 | MMM | 3M Company Financial Report 23rd of July 2024 | PairCorr |
| 0.49 | AA | Alcoa Corp Financial Report 17th of July 2024 | PairCorr |
| 0.46 | CVX | Chevron Corp Financial Report 26th of July 2024 | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Windtree Therapeutics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Windtree Therapeutics market risk premium is the additional return an investor will receive from holding Windtree Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Windtree Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Windtree Therapeutics' alpha and beta are two of the key measurements used to evaluate Windtree Therapeutics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 102.05 | |||
| Semi Deviation | 34.05 | |||
| Standard Deviation | 191.55 | |||
| Variance | 36689.49 |
Windtree Stock Against Markets
Picking the right benchmark for Windtree Therapeutics pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Windtree Therapeutics pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Windtree Therapeutics is critical whether you are bullish or bearish towards Windtree Therapeutics at a given time. Please also check how Windtree Therapeutics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Windtree Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Windtree Therapeutics Corporate Management
Elected by the shareholders, the Windtree Therapeutics' board of directors comprises two types of representatives: Windtree Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Windtree. The board's role is to monitor Windtree Therapeutics' management team and ensure that shareholders' interests are well served. Windtree Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Windtree Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| George Cox | VP Operations | Profile | |
| Eric MBA | VP COO | Profile | |
| Pratap Paruchuru | Ex Devel | Profile | |
| Craig Fraser | CEO Pres | Profile | |
| John Hamill | VP CFO | Profile | |
| Steven Simonson | VP Officer | Profile | |
| Ronald Dundore | Ex Quality | Profile |
How to buy Windtree Pink Sheet?
Before investing in Windtree Therapeutics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Windtree Therapeutics. To buy Windtree Therapeutics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Windtree Therapeutics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Windtree Therapeutics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Windtree Therapeutics stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Windtree Therapeutics stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Windtree Therapeutics, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Windtree Pink Sheet please use our How to Invest in Windtree Therapeutics guide.
Already Invested in Windtree Therapeutics?
The danger of trading Windtree Therapeutics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Windtree Therapeutics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Windtree Therapeutics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Windtree Therapeutics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Windtree Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Windtree Pink Sheet is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Windtree Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Windtree Therapeutics Stock: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Windtree Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Windtree Pink Sheet please use our How to Invest in Windtree Therapeutics guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Windtree Pink Sheet analysis
When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |